Keenan Rosado
Physician Assistant · Charleston, SCNPI 1356068852
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 434 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 434 payments — averaging $22.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Sanofi-aventis U.S. LLC$951
- Xeris Pharmaceuticals, Inc.$861
- Novo Nordisk$824
- Insulet Corporation$812
- Amgen$731
- plus $4K from 32 others
What the payments were for
- Food & beverage$9,751100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 59 | $1,254 |
| Sanofi-aventis U.S. LLC | 27 | $951 |
| Xeris Pharmaceuticals, Inc. | 48 | $861 |
| Novo Nordisk | 40 | $824 |
| Insulet Corporation | 24 | $812 |
| Amgen(2 entities) | 38 | $731 |
| Corcept Therapeutics | 43 | $594 |
| BETA Bionics, Inc. | 12 | $444 |
| Cequr Corporation | 3 | $265 |
| Recordati_rare_diseases_inc. | 11 | $254 |
| AstraZeneca(2 entities) | 12 | $244 |
| Astellas Pharma US Inc | 11 | $230 |
| Tandem Diabetes Care, Inc. | 9 | $221 |
| Dexcom, Inc. | 6 | $199 |
| Medtronic | 9 | $198 |
| IBSA Pharma Inc. | 11 | $189 |
| Boehringer Ingelheim | 8 | $168 |
| Amneal Pharmaceuticals LLC | 7 | $146 |
| Radius Health, Inc. | 6 | $130 |
| Ascendis Pharma Endocrinology Inc | 4 | $100 |
| Ascensia Diabetes Care US Inc. | 4 | $98 |
| Novartis | 5 | $94 |
| Antares Pharma, Inc. | 5 | $86 |
| AbbVie | 4 | $83 |
| Chiesi USA, Inc. | 3 | $81 |
| Bayer | 3 | $71 |
| Tolmar, Inc. | 4 | $57 |
| Kyowa Kirin, Inc. | 2 | $51 |
| Abbott | 2 | $45 |
| Ultragenyx Pharmaceutical Inc. | 2 | $44 |
| Halozyme Inc | 2 | $38 |
| Esteve Pharmaceuticals LLC | 2 | $35 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Neurocrine Biosciences, Inc. | 1 | $30 |
| Acella Pharmaceuticals, LLC | 2 | $29 |
| Arkray USA, Inc. | 1 | $21 |
| Sequel Med Tech, LLC | 1 | $21 |
| Renalytix AI, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,751 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 140 | $211,902 |
| TrulicityDulaglutide | 115 | $162,658 |
| JardianceEmpagliflozin | 102 | $116,984 |
| OzempicSemaglutide | 72 | $109,670 |
| FarxigaDapagliflozin Propanediol | 67 | $83,781 |
| RybelsusSemaglutide | 20 | $33,597 |
| Tresiba Flextouch U-200Insulin Degludec | 18 | $30,917 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $28,991 |
| InvokanaCanagliflozin | 17 | $27,797 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 110 | $25,682 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 18 | $21,484 |
| JanuviaSitagliptin Phosphate | 24 | $21,079 |
| Xigduo XrDapaglifloz Propaned/Metformin | 17 | $20,209 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $17,478 |
| Humalog Kwikpen U-100Insulin Lispro | 31 | $16,479 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $1,254 | $381,519287 claims |
| Novo NordiskOzempic, Rybelsus | $824 | $143,26792 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $168 | $138,468120 claims |
| AstraZenecaFarxiga | $244 | $83,78167 claims |
| AbbVieSynthroid, Armour Thyroid | $83 | $7,84798 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $146 | $4,152342 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $29 | $92120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Charleston
- Michael OvercashCharleston$210K
- Elizabeth HardingCharleston$28K
- Whitney PutillionCharleston$18K
- Corin JaynesCharleston$17K
- Karen ByrdCharleston$16K
- Colleen ManningCharleston$14K
- Kara GayCharleston$13K
- John RicheyCharleston$12K
- John HendrickCharleston$11K
- Ashley MackintoshCharleston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.